Literature DB >> 2798220

Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases.

J Soares1, E Limbert, M Sobrinho-Simões.   

Abstract

The clinico-pathologic features of ten cases of the diffuse sclerosing variant (DSV) of papillary carcinoma of the thyroid (PCT) are presented and compared with those of 259 common PCT diagnosed during the same period at the Instituto Português de Oncologia (Centro de Lisboa). The primary therapeutic approach was basically the same in every case and follow-up information was obtained in every patient. DSV comprises 3.4% of our series of PCT. Patients with DSV are suggestively younger (34.7 +/- 19.9), than those with common PCT (42.3 +/- 16.1) regional lymph node metastases and distant metastases are significantly greater in DSV (100.0% and 50.0%, respectively) than in common PCT (38.6% and 14.3%, respectively). No significant differences were found between the two groups with regard to sex-ratio, extrathyroid invasion and mortality rate. No differences were either found regarding the immunohistochemical results: neoplastic cells of both groups showed immunoreactivity with antisera for thyroglobulin, epidermal keratins, S-100 protein and NSE. Some foci of three DSV cases displayed histological and histochemical features resembling those of the so-called mucoepidermoid carcinoma. It is concluded that a) DSV is an exceptional example of PCT in which most of the usual morphologic features of this type of carcinoma are overexpressed; b) DSV is not exclusively found in young patients and, in older patients, merges with other variants of PCT; c) DSV is indeed a more aggressive tumor than common PCT and should therefore be treated accordingly regardless of the age of the patients.

Entities:  

Mesh:

Year:  1989        PMID: 2798220     DOI: 10.1016/S0344-0338(89)80252-3

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  15 in total

1.  Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Authors:  Lester D R Thompson; Jacqueline A Wieneke; Clara S Heffess
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Leu-M 1 immunoreactivity in papillary carcinomas of the thyroid gland; microcarcinoma, encapsulated, conventional and diffuse sclerosing subtypes.

Authors:  M Alejo; G Peiro; E Oliva; X Matias-Guiu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases.

Authors:  Jennifer Dettloff; Raja R Seethala; Todd M Stevens; Margaret Brandwein-Gensler; Barbara A Centeno; Kristen Otto; Julia A Bridge; Justin A Bishop; Marino E Leon
Journal:  Head Neck Pathol       Date:  2016-07-11

4.  Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.

Authors:  Junko Akaishi; Kiminori Sugino; Kaori Kameyama; Chie Masaki; Kenichi Matsuzu; Akifumi Suzuki; Takashi Uruno; Keiko Ohkuwa; Hiroshi Shibuya; Wataru Kitagawa; Mitsuji Nagahama; Kazuo Shimizu; Koichi Ito
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

5.  Predictive factors for recurrence from a series of 74 children and adolescents with differentiated thyroid cancer.

Authors:  Francoise Borson-Chazot; Sylvain Causeret; Jean-Christophe Lifante; Marylin Augros; Nicole Berger; Jean-Louis Peix
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

6.  Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.

Authors:  David F Schneider; Dawn Elfenbein; Ricardo V Lloyd; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-08-05       Impact factor: 5.344

7.  Diffuse sclerosing variant of papillary thyroid carcinoma with primary squamous cell carcinoma.

Authors:  N Kebapci; B Efe; S Kabukcuoglu; A Akalin; M Kebapci
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

8.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

9.  Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves' disease).

Authors:  Gladell P Paner; Jennifer L Hunt; Marlyn C Ciesla; Steven DeJong; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

10.  Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid.

Authors:  Y Imamura; Y Kasahara; M Fukuda
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.